Marjon A de Boer (M A De Boer, M A de Boer)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Helicobacter Pylori Infection

Top Venues

Human reproduction (Oxford, England)

European journal of hospital pharmacy : science and practice

Hypertension in pregnancy

This page only lists publications with an associated author ORCID identifier.

Publications

P M van Baar, W F J Grijzenhout, Marjon A de Boer, Christianne J M De Groot, Eva Pajkrt, Birit F P Broekman, Mariëlle G van Pampus
Considering multifetal pregnancy reduction in triplet pregnancies: do we forget the emotional impact on fathers? A qualitative study from The Netherlands. Human reproduction (Oxford, England) 39 (3) (2024)
P M van Baar, W F J Grijzenhout, Marjon A de Boer, Christianne J M De Groot, Eva Pajkrt, Birit F P Broekman, Mariëlle G van Pampus
Considering multifetal pregnancy reduction in triplet pregnancies: do we forget the emotional impact on fathers? A qualitative study from The Netherlands. Human reproduction (Oxford, England) (2024)
A F Leeuwerik, Lisanne N van Merendonk, Marjon A de Boer, A J Wilhelm, A Kolkman, Pierre M Bet
A new approach to drug intravenous compatibility research: the case of obstetric parenteral drugs. European journal of hospital pharmacy : science and practice (2023)
Emilie V J van Limburg Stirum, Larissa I van der Windt, Charlotte E van Dijk, Anneloes L van Baar, Aleid G Leemhuis, Madelon van Wely, Marjon A de Boer, Janneke van 't Hooft, Martijn A Oudijk, Eva Pajkrt, null null
Pessary or progesterone to prevent preterm birth in women with short cervical length: protocol of the 4-6 year follow-up of a randomised controlled trial (Quadruple-P). BMJ open 12 (8) (2022)
Anadeijda J E M C Landman, Emilie V J van Limburg Stirum, Janneke van 't Hooft, Aleid G Leemhuis, Martijn J J Finken, Anneloes L van Baar, Tessa J Roseboom, Anita C J Ravelli, Madelon van Wely, Jaap Oosterlaan, Rebecca C Painter, Eva Pajkrt, Martijn A Oudijk, Marjon A de Boer
Long-term outcomes following antenatal exposure to low-dose aspirin: study protocol for the 4-year follow-up of the APRIL randomised controlled trial. BMJ open 12 (8) (2022)
Noralie N Schonewille, C N H Abheiden, Anouk Bokslag, A Thijs, Christianne J M De Groot, Johanna I P de Vries, Marjon A de Boer
Cardiovascular risk after hypertensive disorders of pregnancy in women with and without inheritable Thrombophilia. Hypertension in pregnancy 39 (2) (2020)